Surya Pharmaceuticals Ltd. Company History and Annual Growth Details

1992
- Surya Pharmaceuticals was incorporated

1993
- Surya Pharmaceuticals began to manufacure its penicillin derivatives in 1993.

- cephlosporins (first generation), antihistamines (non-sedative), drug intermediates and drug formulations.

2003

-The company is focussing on R&D activities to optimise cost, increase process yield, inventing better process and waste recovery methods. The R&D specialises in alkylation, bromination, cyanation, iodination, diazotization, friedal crafts, acylation, substitution, reaction, mannich reaction, condensation, grignard reaction, cyclization, esterfication, hydrolysis, hetrocyclic synthesis, typical oxidation, etc.

- The company is hitting the market with a Rs 13.5 crore initial public offer (IPO) at a premium of Rs 35.The IPO proceeds will be used to meet working capital requirements and to fund a project to set up infrastructure and machinery for its research and development facility.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article